INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Type | Shares Traded | Price |
---|---|---|---|---|---|
Dec 10, 2021 |
EVP Research and Development
|
EVP Research and Development | Other acquisition or disposition | -- | -- |
Dec 10, 2021 |
EVP Research and Development
|
EVP Research and Development | Other acquisition or disposition | -- | -- |
Dec 08, 2021 |
EVP Research and Development
|
EVP Research and Development | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,926 | -- |
Dec 08, 2021 |
EVP Research and Development
|
EVP Research and Development | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 12,494 | -- |
May 18, 2021 |
EVP Research and Development
|
EVP Research and Development | Other acquisition or disposition | -- | -- |
May 18, 2021 |
EVP Research and Development
|
EVP Research and Development | Other acquisition or disposition | -- | -- |
May 17, 2021 |
EVP Research and Development
|
EVP Research and Development | Open market or private sale of non-derivative or derivative security | 3,379 | $518.63 |
May 17, 2021 |
EVP Research and Development
|
EVP Research and Development | Open market or private sale of non-derivative or derivative security | 10,336 | $519.47 |
May 17, 2021 |
EVP Research and Development
|
EVP Research and Development | Open market or private sale of non-derivative or derivative security | 3,806 | $520.17 |
May 14, 2021 |
EVP Research and Development
|
EVP Research and Development | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,000 | $179.13 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.